tirzepatide gip/glp-1 dual action drops gip/glp 1-agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes Dose-equivalence reference based on pivotal

Shkorfu, W., Fadel, A., Hamsho, M., Ranneh, Y., & Shahbaz, H

1 Introduction Type 2 diabetes (T2D) is a complex and chronic metabolic disorder characterized by insulin resistance, progressive beta-cell dysfunction, and persistent hyperglycemia

The appetite-suppressing effects of semaglutide GLP-1 usually become noticeable within a few weeks, after initiating the treatment, and it doesnt take long for individuals to begin noticing weight loss

The brain is the most intricate network structure which facilitates a concerted communication between single neurons, different neuronal populations, and remote brain (Gupta et al., 2020)

It performs many roles, but primarily it acts as your most powerful antioxidant, combating free radicals and oxidative stress that can slow and eventually break down cellular function